Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15245 | 654 | 36.6 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
36 | 32479 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL INTRAEPITHELIAL NEOPLASIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHROMOSOME 3Q26 | Author keyword | 4 | 75% | 0% | 3 |
2 | PAN RAS | Author keyword | 3 | 60% | 0% | 3 |
3 | HUMAN TELOMERASE GENE | Author keyword | 2 | 67% | 0% | 2 |
4 | HTERC | Author keyword | 2 | 26% | 1% | 6 |
5 | 3Q GAIN | Author keyword | 1 | 100% | 0% | 2 |
6 | BEREICH MOL GYNAKOL GEBURTSHILFE | Address | 1 | 100% | 0% | 2 |
7 | GENOM ENFERMEDADES COMPLEJAS | Address | 1 | 100% | 0% | 2 |
8 | HTERC GENE | Author keyword | 1 | 100% | 0% | 2 |
9 | HUMAN TELOMERASE RNA GENE | Author keyword | 1 | 100% | 0% | 2 |
10 | IMMUNOFLUORESCENT ANTIBODY ASSAY | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHROMOSOME 3Q26 | 4 | 75% | 0% | 3 | Search CHROMOSOME+3Q26 | Search CHROMOSOME+3Q26 |
2 | PAN RAS | 3 | 60% | 0% | 3 | Search PAN+RAS | Search PAN+RAS |
3 | HUMAN TELOMERASE GENE | 2 | 67% | 0% | 2 | Search HUMAN+TELOMERASE+GENE | Search HUMAN+TELOMERASE+GENE |
4 | HTERC | 2 | 26% | 1% | 6 | Search HTERC | Search HTERC |
5 | 3Q GAIN | 1 | 100% | 0% | 2 | Search 3Q+GAIN | Search 3Q+GAIN |
6 | HTERC GENE | 1 | 100% | 0% | 2 | Search HTERC+GENE | Search HTERC+GENE |
7 | HUMAN TELOMERASE RNA GENE | 1 | 100% | 0% | 2 | Search HUMAN+TELOMERASE+RNA+GENE | Search HUMAN+TELOMERASE+RNA+GENE |
8 | IMMUNOFLUORESCENT ANTIBODY ASSAY | 1 | 50% | 0% | 2 | Search IMMUNOFLUORESCENT+ANTIBODY+ASSAY | Search IMMUNOFLUORESCENT+ANTIBODY+ASSAY |
9 | TELOMERASE RNA GENE | 1 | 100% | 0% | 2 | Search TELOMERASE+RNA+GENE | Search TELOMERASE+RNA+GENE |
10 | TERC | 1 | 13% | 1% | 7 | Search TERC | Search TERC |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RECURRENT PATTERN | 49 | 64% | 7% | 48 |
2 | TELOMERASE GENE TERC | 24 | 67% | 3% | 22 |
3 | GENOMIC AMPLIFICATION | 19 | 52% | 4% | 26 |
4 | TERC | 10 | 47% | 2% | 16 |
5 | TELOMERASE RNA GENE | 3 | 57% | 1% | 4 |
6 | 3Q26 | 3 | 30% | 1% | 9 |
7 | NONRANDOM CHROMOSOME CHANGES | 3 | 50% | 1% | 4 |
8 | FREQUENT GAIN | 2 | 44% | 1% | 4 |
9 | HYBRIDIZATION REVEALS | 2 | 36% | 1% | 5 |
10 | MICROSATELLITE POLYMORPHISMS | 2 | 16% | 2% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - A systematic review and meta-analysis | 2014 | 8 | 74 | 47% |
Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis | 2010 | 13 | 33 | 58% |
Epidermal growth factor receptor as a biomarker for cervical cancer | 2011 | 30 | 96 | 40% |
Fluorescence In Situ Hybridization Testing for the Diagnosis of High-Grade Cervical Abnormalities: A Systematic Review | 2014 | 1 | 31 | 58% |
Emerging Biological Treatments for Uterine Cervical Carcinoma | 2014 | 9 | 128 | 19% |
The role of TP53 in cervical carcinogenesis | 2003 | 67 | 47 | 28% |
The molecular genetics of cervical carcinoma | 1999 | 128 | 107 | 23% |
Tissue biomarkers as prognostic variables of cervical cancer | 2013 | 12 | 179 | 18% |
Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review | 2013 | 10 | 42 | 19% |
PROGNOSTIC CELL BIOLOGICAL MARKERS IN CERVICAL CANCER PATIENTS PRIMARILY TREATED WITH (CHEMO)RADIATION: A SYSTEMATIC REVIEW | 2011 | 21 | 71 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BEREICH MOL GYNAKOL GEBURTSHILFE | 1 | 100% | 0.3% | 2 |
2 | GENOM ENFERMEDADES COMPLEJAS | 1 | 100% | 0.3% | 2 |
3 | SSZOG | 1 | 100% | 0.3% | 2 |
4 | 720 RUTLAND AVE | 1 | 50% | 0.2% | 1 |
5 | ADM P IDENT RUSSIAN FEDERAT | 1 | 50% | 0.2% | 1 |
6 | BIOCHEM OPTHALMOL | 1 | 50% | 0.2% | 1 |
7 | CLIN HLTH POLICY STUDY | 1 | 50% | 0.2% | 1 |
8 | CLIN SCI TECHNOLCLINTEC | 1 | 50% | 0.2% | 1 |
9 | DIFERENCIAC CELULAR CANC | 1 | 50% | 0.2% | 1 |
10 | DOCTORS DIAGNOST | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000235161 | P16INK4A//L1 CAPSID PROTEIN//PROEX C |
2 | 0.0000164286 | LIFESPAN MED//CYTOGENET FISH GENOTOXICOL//BUCCAL SMEARS |
3 | 0.0000137720 | PEG10//RASPBERRY EXTRACT//NEEM LEAF EXTRACT |
4 | 0.0000130955 | E6//PAPILLOMAVIRUS//E7 |
5 | 0.0000089897 | HCCR 1//HUMAN CERVICAL CANCER ONCOGENE//HCCR |
6 | 0.0000088987 | OVARIAN CARCINOMAS//CANC MONTREAL//6Q27 |
7 | 0.0000081356 | CLIN BREAST CARE PROJECT//16Q243//CHROMOSOMAL SCANNING |
8 | 0.0000079042 | HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER |
9 | 0.0000077706 | ATYPICAL GLANDULAR CELLS//ADENOMA MALIGNUM//ADENOCARCINOMA IN SITU |
10 | 0.0000070739 | PRIMARY SQUAMOUS CELL CARCINOMA OF THE ENDOMETRIUM//ICHTHYOSIS UTERI//ENDOMETRIAL AND OVARIAN CARCINOMAS |